News Releases & Statements
News Releases & Statements
LLS President & CEO, Louis J. DeGennaro, Ph.D., Announces Retirement
Posted On: May 3, 2022 Read More
The Leukemia & Lymphoma Society is Expanding What’s Possible for Blood Cancer Patients and their Families
Posted On: April 26, 2022(Rye Brook, NY, April 26, 2022) – The Read More
Hundreds to Climb Iconic Bank of America Tower to End Blood Cancer
Posted On: April 18, 2022See the full multimedia release here.
Read More
LLS Statement on Confirmation of Associate Justice Ketanji Brown Jackson
Posted On: April 7, 2022Rye Brook, N.Y., April 7, 2022 — The Leukemia & Lymphoma Society (LLS) applauds the confirmation of Ketanji Brown Jackson as the next Associate Justice of the U.S. Supreme Court. Her confirmation represents a historic moment.
Read More
Royalty Pharma Announces Charitable Alliance with The Leukemia & Lymphoma Society (LLS) To Advance Initiatives that Address Healthcare Disparities in Blood Cancer Care and Treatment
Posted On: March 29, 2022NEW YORK and RYE BROOK, NY, MARCH 29, 2022 Read More
Join Us in Supporting Childhood Cancer Patients in Ukraine
Posted On: March 7, 2022As a healthcare organization dedicated to supporting all blood cancer patients, we at The Leukemia & Lymphoma Society (LLS) are horrified by the dire conditions facing childhood cancer patients in hospitals across Ukraine. Many are bunkering down with their families as medical staff deliver compromised treatments, face dwindling supplies, and evacuation becomes increasingly difficult.
Read More
FDA Approves New Drug for Patients with Rare Blood Cancer (Myelofibrosis)
Posted On: March 1, 2022Rye Brook, N.Y., February 28, 2022 – The Food and Drug Administration (FDA) recently approved a drug for the treatment of intermediate or high-risk primary or secondary myelofibrosis, the first specifically for patients with severely low platelet counts (thrombocytopenia).
Read MoreMedia Requests
Please send all media-related inquiries and interview requests to mediarelations@lls.org. An LLS representative will respond as soon as possible.